OptimizeRx CorporationOptimizeRx CorporationOptimizeRx Corporation

OptimizeRx Corporation

No trades
See on Supercharts

OPRX fundamentals

An in-depth look to OptimizeRx Corporation operating, investing, and financing activities

OPRX free cash flow for Q1 24 is 2.09 M USD. For 2023, OPRX free cash flow was -7.33 M USD and operating cash flow was -7.24 M USD.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Free cash flowYoY growth